Skip to main content
Explore URMC
menu
Clinical & Translational Science Institute / Funding / Diversity/Re-Entry Supplements

Diversity and Re-Entry Supplement Grants

The National Institutes of Health offers supplemental funding to current NIH grants – including the UL1 grant supporting the UR CTSI – to promote diversity among the health research workforce. Trainees, postdoctoral scholars and early-stage faculty from groups that are underrepresented in health research and individuals whose careers have been interrupted by qualifying life events can apply for supplemental funding through the UR CTSI to conduct research that aligns with UR CTSI priorities.

Diversity and re-entry supplement awardees will receive two years of salary support as well as fringe benefits, travel and limited supplies. The UR CTSI can select up to two diversity and two re-entry candidates each year to develop full supplement applications to the UR CTSI’s UL1 grant from the National Center for Advancing Translational Science (NCATS). Supplement candidates must not have effort on other Public Health Services funded grants.

Jump to:   Eligibility   |   Apply   |   Past Awardees

Eligibility

Diversity Supplements

These grants are designed for individuals who are underrepresented in the biomedical sciences, including:

Re-Entry Supplements

These grants are designed for individuals whose careers have been completely or partially interrupted for one to eight years due to:

  • child rearing
  • illness or injury of self or loved one
  • relocation to for a spouse, partner or close family member
  • pursuit of non-research endeavors to pay off debts incurred in obtaining a doctoral degree
  • military service

Candidates should be in complete or partial hiatus from research activities at the time of application and should not be engaged in full-time paid research activities. Preference will be given to those on complete hiatus from research activities.

Learn More About the Supplements

NCATS Brochure | CTSA Program Guidance
Diversity FAQ | Re-Entry FAQ

This Funding Opportunity Announcement is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial.

The proposed research must align with the strategic goals and aims of the UR CTSI’s UL1 grant:

  1. Translational Research Integration: Accelerate integration with the healthcare system for translation of research into transformative clinical practice and health improvement.
  2. Data Excellence/Informatics: Extend our data ecosystem to further accelerate translational research via seamless research, clinical, and population data integration, innovative analytical methods, and workforce training in data analytics and health informatics.
  3. Engagement: Accelerate translational research collaborations at the local and national levels across the spectrum of stakeholders with development of novel collaboration methods.
  4. Workforce Development: Train the next generation of translational science workforce leaders in the team science, implementation science, and regulatory skills necessary to speed the translation of discoveries to clinical application.
  5. Methods and Processes: Catalyze the development, implementation and dissemination of methods and processes that advance translational research locally and nationally across the CTSA Consortium.

Apply

Complete the online submission form by Thursday, July 1, 2021.

  • Submission includes:
    • NIH-style one-page specific aims
    • abbreviated NIH-style biosketch (name, position title, education and training, positions and employment, all published work, and research support)
  • Incomplete applications will not be considered for review.
  • We estimate it will take four weeks to review submitted applications.

Final applications must be submitted to NCATS by Friday, November 1, 2021.

If you have any questions, please email John_Cullen@urmc.rochester.edu

Past Awardees

Wyatt C. Hall, Ph.D.
Diversity Supplement, 2018 - 2020
Developing A Validated Quantitative Scale of Language Deprivation in the Deaf Population.